Search Results - "R., Mehran"

Contrast-induced nephropathy: Definition, epidemiology, and patients at risk by Mehran, R., Nikolsky, E.

“…Radiological procedures utilizing intravascular iodinated contrast media injections are being widely applied for both diagnostic and therapeutic purposes. This…”
Get full text

Rapid Identification by Surface-Enhanced Raman Spectroscopy of Cancer Cells at Low Concentrations Flowing in a Microfluidic Channel by Pallaoro, Alessia, Hoonejani, Mehran R, Braun, Gary B, Meinhart, Carl D, Moskovits, Martin

“…Reliable identification and collection of cells from bodily fluids is of growing interest for monitoring patient response to therapy and for early detection of…”
Get full text

Rapid Detection of Drugs of Abuse in Saliva Using Surface Enhanced Raman Spectroscopy and Microfluidics by Andreou, Chrysafis, Hoonejani, Mehran R, Barmi, Meysam R, Moskovits, Martin, Meinhart, Carl D

“…We present a microfluidic device that detects trace concentrations of drugs of abuse in saliva within minutes using surface-enhanced Raman spectroscopy (SERS)…”
Get full text

Closing the gap: cardiovascular disease in women by Nathani, M, Vogel, B, Mehran, R

“…Cardiovascular disease (CVD) in women remains understudied, under-recognized, underdiagnosed and undertreated. Initiatives such as the Women and Cardiovascular…”
Get full text

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2) by Kappetein, Arie Pieter, Head, Stuart J., Généreux, Philippe, Piazza, Nicolo, van Mieghem, Nicolas M., Blackstone, Eugene H., Brott, Thomas G., Cohen, David J., Cutlip, Donald E., van Es, Gerrit-Anne, Hahn, Rebecca T., Kirtane, Ajay J., Krucoff, Mitchell W., Kodali, Susheel, Mack, Michael J., Mehran, Roxana, Rodés-Cabau, Josep, Vranckx, Pascal, Webb, John G., Windecker, Stephan, Serruys, Patrick W., Leon, Martin B.

“…OBJECTIVES The aim of the current Valve Academic Research Consortium (VARC)-2 initiative was to revisit the selection and definitions of transcatheter aortic…”
Get full text

Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy by Narula, Amar, Mehran, Roxana, Weisz, Giora, Dangas, George D, Yu, Jennifer, Généreux, Philippe, Nikolsky, Eugenia, Brener, Sorin J, Witzenbichler, Bernhard, Guagliumi, Giulio, Clark, Avery E, Fahy, Martin, Xu, Ke, Brodie, Bruce R, Stone, Gregg W

“…We sought to examine the short- and long-term outcomes of patients who developed contrast-induced acute kidney injury (CI-AKI; defined as an increase in serum…”
Get full text

Primary prevention of cardiovascular disease in women by Gray, M P, Vogel, B, Mehran, R, Leopold, J A, Figtree, G A

“…Ischemic heart disease is the primary cause of cardiovascular disease (CVD) mortality in both men and women. Strategies targeting traditional modifiable risk…”
Get full text

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium by LEON, Martin B, PIAZZA, Nicoto, MOREL, Marie-Angèle, PETERSEN, John, POPMA, Jeffrey J, TAKKENBERG, Johanna J. M, VAHANIAN, Alec, VAN ES, Gerrit-Anne, VRANCKX, Pascal, WEBB, John G, WINDECKER, Stephan, SERRUYS, Patrick W, NIKOLSKY, Eugenia, BLACKSTONE, Eugene H, CUTLIP, Donald E, PIETER KAPPETEIN, Arie, KRUCOFF, Mitchell W, MACK, Michael, MEHRAN, Roxana, MILLER, Craig

“…To propose standardized consensus definitions for important clinical endpoints in transcatheter aortic valve implantation (TAVI), investigations in an effort…”
Get full text

Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction by Sorajja, Paul, Gersh, Bernard J., Cox, David A., McLaughlin, Michael G., Zimetbaum, Peter, Costantini, Costantino, Stuckey, Thomas, Tcheng, James E., Mehran, Roxana, Lansky, Alexandra J., Grines, Cindy L., Stone, Gregg W.

“…Aims We sought to investigate the impact of multivessel coronary artery disease (CAD) on reperfusion success and prognosis following primary percutaneous…”
Get full text

Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer by Ajani, J.A., Correa, A.M., Hofstetter, W.L., Rice, D.C., Blum, M.A., Suzuki, A., Taketa, T., Welsh, J., Lin, S.H., Lee, J.H., Bhutani, M.S., Ross, W.A., Maru, D.M., Macapinlac, H.A., Erasmus, J., Komaki, R., Mehran, R.J., Vaporciyan, A.A., Swisher, S.G.

“…Approximately 25% of patients with esophageal cancer (EC) who undergo preoperative chemoradiation, achieve a pathologic complete response (pathCR). We…”
Get full text

Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma by Zhou, N, Mitchell, K G, Corsini, E M, Truong, V T T, Antonoff, M B, Mehran, R J, Rajaram, R, Rice, D C, Roth, J A, Sepesi, B, Swisher, S G, Vaporciyan, A A, Walsh, G L, Ajani, J A, Hofstetter, W L

“…Long-term survival outcomes of trimodal therapy (TMT; chemoradiation plus surgery) and bimodal therapy (BMT; chemoradiation) have seldom been analysed. In a…”
Get full text

Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach by Nikolsky, Eugenia, Mehran, Roxana, Dangas, George, Fahy, Martin, Na, Yingbo, Pocock, Stuart J., Lincoff, A. Michael, Stone, Gregg W.

“…Aims Major bleeding after percutaneous coronary intervention (PCI) is an independent risk factor for early and late mortality. We developed and validated a…”
Get full text

Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience by Mitchell, K G, Nelson, D B, Corsini, E M, Vaporciyan, A A, Antonoff, M B, Mehran, R J, Rice, D C, Roth, J A, Sepesi, B, Walsh, G L, Bhutani, M S, Maru, D M, Wu, C C, Nguyen, Q-N, Ajani, J A, Swisher, S G, Hofstetter, W L

“…SUMMARY The survival advantage associated with the addition of surgical therapy in esophageal squamous cell carcinoma (ESCC) patients who demonstrate a…”
Get full text

Aggregation Kinetics of SERS-Active Nanoparticles in Thermally Stirred Sessile Droplets by Barmi, Meysam R, Andreou, Chrysafis, Hoonejani, Mehran R, Moskovits, Martin, Meinhart, Carl D

“…The aggregation kinetics of silver nanoparticles in sessile droplets were investigated both experimentally and through numerical simulations as a function of…”
Get full text

Inertial flow focusing: a case study in optimizing cellular trajectory through a microfluidic MEMS device for timing-critical applications by Patterson, Luke H.C., Walker, Jennifer L., Naivar, Mark A., Rodriguez-Mesa, Evelyn, Hoonejani, Mehran R., Shields, Kevin, Foster, John S., Doyle, Adele M., Valentine, Megan T., Foster, Kimberly L.

“…Although microfluidic micro-electromechanical systems (MEMS) are well suited to investigate the effects of mechanical force on large populations of cells,…”
Get full text

Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications by Suraokar, M.B., Nunez, M.I., Diao, L., Chow, C.W., Kim, D., Behrens, C., Lin, H., Lee, S., Raso, G., Moran, C., Rice, D., Mehran, R., Lee, J.J., Pass, H.I., Wang, J., Momin, A.A., James, B.P., Corvalan, A., Coombes, K., Tsao, A., Wistuba, I.I.

“…Malignant pleural mesothelioma (MPM) is a lethal neoplasm exhibiting resistance to most treatment regimens and requires effective therapeutic options. Though…”
Get full text

Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC) by Weissferdt, A., Sepesi, B., Pataer, A., Kalhor, N., Moran, C.A., William, W.N., Le, X., Glisson, B., Skoulidis, F., Blumenschein, G., Zhang, J., Altan, M., Rice, D., Mehran, R., Lee, J.J., Vaporciyan, A., Gibbons, D.L., Swisher, S.G., Heymach, J.V., Cascone, T.

Get full text

Patient-Reported Symptoms: Differences Between Men and Women Following Pulmonary Resection by Antonoff, M, Ragalie, W, Sepesi, B, Roth, J, Walsh, G, Hofstetter, W, Swisher, S.G, Rice, D.C, Vaporciyan, A.A, Mehran, R

Get full text

Endothelial progenitor cell mobilization by preoperative exercise: a bone marrow response associated with postoperative outcome by Schier, R., El-Zein, R., Cortes, A., Liu, M., Collins, M., Rafat, N., Teschendorf, P., Wu, Hua-Kang, Heymach, J., Mehran, R., Riedel, B.

“…Preoperative anaemia is associated with increased morbidity in patients undergoing major surgery. Whether erythrocytes are the only bone-marrow-derived cell…”
Get full text

Stereotactic Ablative Body Radiation for Pulmonary Metastases: Should We Consider Dose Escalation for More Unresponsive Histologies? by Nguyen, Q.N, LU, Y, Tang, C, Chance, W.W, Mehran, R, Balter, P, Welsh, J.W, Hahn, S.M, Jeter, M.D, Komaki, R.U, Gomez, D.R, Chang, J.Y, Liao, Z

Get full text